Introduction
This article is for research and educational use only. The GLP-1 receptor's large N-terminal extracellular domain (ECD) is often drawn as an antenna waiting for a peptide. A 2020 crystal structure of the full-length receptor with no peptide bound suggests something different: in that structure the ECD folds down and sits against the receptor's own transmembrane core.
That matters if you read receptor structures, because most class B GPCR structures were solved with an agonist peptide in place. A ligand-free, closed ECD gives a baseline to compare them against. Below we cover what the ECD normally does, how the closed state is built, how researchers checked that it's real, and where a later cryo-EM structure complicates the picture.
What the extracellular domain does in a class B GPCR
In short: the ECD is the first docking site for the peptide, and the core of the receptor is the second.
The fold
The GLP-1 receptor has 463 residues and belongs to the class B (secretin-like) GPCR family. Its extracellular domain is roughly 100 to 150 residues long. A review of GLP-1R structure and function describes the fold as two antiparallel beta sheets, an N-terminal alpha helix and three disulfide bonds (pairing residues 46-71, 62-104 and 85-126). Breaking those disulfides with a reducing agent abolished binding of the native peptide in the work it summarizes. A groove lined by the N-terminal helix, a turn, a loop and the C-terminal region forms the ligand-binding site.
The two-domain model
The classic picture is a two-step interaction. The ECD first captures the C-terminal helix of the peptide. That lets the peptide's N-terminus reach the transmembrane core, and that second contact is what the activation step depends on. For a side-by-side look at how two related receptors handle this, see our piece on GLP-1R and GIPR compared by cryo-EM.
The two-domain model says little about where the ECD sits when no peptide is around. That's the gap the ligand-free structure fills.
The peptide-free crystal structure
In short: with nothing in the orthosteric site, the ECD packs against the transmembrane domain.
What was solved
The structure comes from a 2020 Nature Communications paper, "Full-length human GLP-1 receptor structure without orthosteric ligands" (PDB 6LN2). It is an X-ray structure at 3.2 Å resolution of the full-length human receptor in an inactive state. To get crystals, the team used a negative allosteric modulator (PF-06372222) and a non-competitive antibody fragment (Fab7F38). Those are crystallization aids. Keep them in mind when judging how far one structure generalizes.
How the closed ECD packs
The authors call the arrangement a unique closed conformation. The peptide-binding groove of the ECD is juxtaposed with the transmembrane domain (TMD) and touches extracellular loops 1 and 3 (ECL1 and ECL3). Two contacts stand out: an ECD loop (S116 to E127) covers the ECL1 helix (Q211 to S219), and the ECD alpha-A helix (W33 to R40) runs antiparallel to ECL3 (L379 to T386).

